标题
Homoharringtonine and omacetaxine for myeloid hematological malignancies
作者
关键词
Homoharringtonine, Omacetaxine, Chronic myeloid leukemia, Acute myeloid leukemia, Myelodysplastic syndrome
出版物
Journal of Hematology & Oncology
Volume 7, Issue 1, Pages 2
出版商
Springer Nature
发表日期
2014-01-04
DOI
10.1186/1756-8722-7-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia
- (2013) Houda Alachkar et al. Journal of Hematology & Oncology
- Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
- (2013) Jie Jin et al. LANCET ONCOLOGY
- Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation
- (2012) J. Cortes et al. BLOOD
- Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS
- (2011) Lingyun Wu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells
- (2011) E K Allan et al. LEUKEMIA
- The Durable Clearance of the T315I BCR-ABL Mutated Clone in Chronic Phase Chronic Myelogenous Leukemia Patients on Omacetaxine Allows Tyrosine Kinase Inhibitor Rechallenge
- (2010) Franck E. Nicolini et al. Clinical Lymphoma Myeloma & Leukemia
- Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia
- (2010) Liu-Fang Gu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo
- (2009) David M. Lucas et al. BLOOD
- c-Myc and eIF4F Constitute a Feedforward Loop That Regulates Cell Growth: Implications for Anticancer Therapy
- (2009) C.-J. Lin et al. CANCER RESEARCH
- U2504 Determines the Species Specificity of the A-Site Cleft Antibiotics:
- (2009) Güliz Gürel et al. JOURNAL OF MOLECULAR BIOLOGY
- Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice
- (2009) Y Chen et al. LEUKEMIA
- Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome
- (2009) Lingyun Wu et al. LEUKEMIA & LYMPHOMA
- A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804
- (2008) Richard M. Stone et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- c-Myc and eIF4F Are Components of a Feedforward Loop that Links Transcription and Translation
- (2008) C.-J. Lin et al. CANCER RESEARCH
- Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells
- (2008) Hongyan Tong et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
- (2008) Junya Kuroda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia
- (2008) Y Hu et al. LEUKEMIA
- The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia
- (2007) Zhijian Xiao et al. AMERICAN JOURNAL OF HEMATOLOGY
- Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
- (2007) Wang-Gang Zhang et al. AMERICAN JOURNAL OF HEMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now